A new proprietary analysis of cutting-edge Alzheimer's drugs finds growing excitement around experimental therapies targeting ...

Matt Gentry, Chair of the Department of Biochemistry and Molecular Biology at the University of Florida and co-author of the ...

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Researchers have uncovered a surprising immune-system switch in the brain that could open a new avenue in the fight the ...

The study, published in Frontiers in Immunology, was conducted by researchers from Hofstra University and Northwell Health in ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

Two years is a fairly typical length of time for people with symptoms to receive a diagnosis of Alzheimer’s, even though ...

Jeremy Scott told Newsweek he remembers having a strange experience at a Disney resort years before his diagnosis.

EAU CLAIRE, Wis. (WEAU) - Event organizers are announcing the Walk to End Alzheimer’s - Chippewa Valley this past Saturday ...